1. Home
  2. BDSX vs BGX Comparison

BDSX vs BGX Comparison

Compare BDSX & BGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$15.49

Market Cap

153.3M

Sector

Health Care

ML Signal

HOLD

Logo Blackstone Long Short Credit Income Fund

BGX

Blackstone Long Short Credit Income Fund

HOLD

Current Price

$10.87

Market Cap

135.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
BGX
Founded
2005
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
153.3M
135.2M
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
BDSX
BGX
Price
$15.49
$10.87
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$32.50
N/A
AVG Volume (30 Days)
36.3K
49.1K
Earning Date
05-04-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$88,499,000.00
N/A
Revenue This Year
$25.26
N/A
Revenue Next Year
$19.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.08
N/A
52 Week Low
$0.26
$10.38
52 Week High
$20.21
$12.65

Technical Indicators

Market Signals
Indicator
BDSX
BGX
Relative Strength Index (RSI) 52.46 51.13
Support Level $14.61 $10.76
Resistance Level $16.66 $10.97
Average True Range (ATR) 0.94 0.07
MACD -0.10 0.00
Stochastic Oscillator 24.61 65.79

Price Performance

Historical Comparison
BDSX
BGX

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

About BGX Blackstone Long Short Credit Income Fund

Blackstone Long-Short Credit Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. The company's seeks to achieve its investment objectives by employing a dynamic long-short strategies in a diversified portfolio of loans and fixed-income instruments of predominantly U.S. corporate issuers, including first and second-lien secured loans (Secured Loans) and high-yield corporate bonds of varying maturities.

Share on Social Networks: